Natera, Inc. expanded its Board of Directors from eleven to twelve members and appointed Thomas Lynch as a Class I director, effective June 2, 2026. Dr. Lynch will serve on the Human Capital Committee and will receive compensation consistent with other non-employee directors. Natera, Inc. operates in the healthcare technology sector, providing genetic testing services.
